45 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 May 24
Current report (foreign)
6:29am
sheet values are calculated by write-down of the book value based on decreases in profitability) Raw materials and Supplies: Cost determined by gross
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 May 24
Current report (foreign)
6:24am
63,007 Merchandise and products 62,146 39,202 Income taxes payable 445 1,462 Work in process 38,541 46,094 Short-term loans 415,969 388,195 Raw … materials and supplies 43,223 39,399 Current portion of bonds 317,000 106,715 Income taxes receivables 1,865 2,192 Current portion of long-term loans 50,000
SD
TAK
Takeda Pharmaceutical Co
25 Apr 24
Conflict minerals disclosure
6:04am
with raw materials and ending with the finished product that a patient receives. As a result, Takeda elected to use a “product-centric” approach
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Jul 23
Current report (foreign)
6:18am
or Recycling Raw Materials R&D and Manufacturing End-of-Life Distribution “ We want to deliver products to patients that transform their lives, while minimizing
6-K
EX-99.1
0z8u33x2he0l
23 Jun 23
Current report (foreign)
6:13am
6-K
EX-99.1
graznii
30 May 23
Current report (foreign)
6:14am
6-K
EX-99.1
eow552r
30 May 23
Current report (foreign)
6:11am
SD
zq92 e78jyu2
15 May 23
Conflict minerals disclosure
6:09am
6-K
EX-99.1
wxzl2r5r
31 May 22
Current report (foreign)
6:07am
6-K
EX-99.1
1pqy3n
31 May 22
Current report (foreign)
12:00am
SD
vlajlca2s8427k
13 May 22
Conflict minerals disclosure
6:10am
6-K
b3w j4yi7yr1mchvhx2
11 May 22
Current report (foreign)
6:06am
6-K
EX-99.1
fna558kt58dz dc
29 Jun 21
Current report (foreign)
7:38am
6-K
EX-99.1
6qoscljlpdoq189l
28 May 21
Current report (foreign)
6:03am
6-K
EX-99.1
fhc59f
28 May 21
Current report (foreign)
6:01am